| | Hang Seng Index | 26.540 HKD | 0.000 | 0.000% | 334.86M | 8.90B | 25.846 (+2.686%) HKD as at 2025/12/31 | | |
| | Hang Seng China Enterprises Index | 93.760 HKD | -0.200 | -0.213% | 60.67M | 5.70B | 91.358 (+2.629%) HKD as at 2025/12/31 | | |
| | Hang Seng TECH Index | 5.605 HKD | -0.005 | -0.089% | 626.43M | 3.53B | 5.618 (-0.230%) HKD as at 2026/01/02 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.500 HKD | -0.010 | -0.181% | 99.70M | 553.78M | 5.530 (-0.544%) HKD as at 2026/01/02 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 18.190 HKD | +0.690 | +3.943% | 16.25M | 297.22M | 16.139 (+12.707%) HKD as at 2025/12/31 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.334 HKD | +0.004 | +0.301% | 192.06M | 253.79M | 1.329 (+0.369%) HKD as at 2026/01/02 | | |
| | Hang Seng TECH Index (net total return version) | 12.000 HKD | -0.020 | -0.166% | 20.37M | 245.70M | 11.568 (+3.735%) HKD as at 2025/12/31 | | |
| | Hang Seng TECH Index | 5.700 HKD | -0.020 | -0.350% | 37.42M | 214.20M | 5.493 (+3.772%) HKD as at 2025/12/31 | | |
| | | 10.530 HKD | +0.010 | +0.095% | 13.06M | 137.55M | 10.403 (+1.219%) HKD as at 2025/12/31 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.740 HKD | 0.000 | 0.000% | 60.37M | 104.59M | 1.729 (+0.636%) HKD as at 2026/01/02 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.185 HKD | -0.005 | -0.081% | 16.19M | 100.48M | 6.221 (-0.580%) HKD as at 2026/01/02 | | |
| | London Gold Fixing Price | 3,155.000 HKD | +14.000 | +0.446% | 27.59K | 87.06M | 396.120 (+2.248%) USD as at 2025/12/31 | | |
| | Hang Seng Biotech Index | 15.150 HKD | +0.560 | +3.838% | 5.61M | 83.75M | 14.590 (+3.839%) HKD as at 2026/01/02 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 19.570 HKD | -0.150 | -0.761% | 3.38M | 66.34M | 19.619 (-0.248%) HKD as at 2025/12/31 | | |
| | CSI 300 Index | 54.360 HKD | +0.460 | +0.853% | 1.04M | 56.27M | 53.535 (+1.541%) HKD as at 2025/12/31 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 42.940 HKD | +4.820 | +12.644% | 1.02M | 43.31M | 33.185 (+29.398%) HKD as at 2025/12/31 | | |
| | FTSE China A50 Index | 16.600 HKD | +0.010 | +0.060% | 2.03M | 33.74M | 16.403 (+1.203%) HKD as at 2025/12/31 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 27.240 HKD | +0.180 | +0.665% | 1.17M | 31.93M | 26.367 (+3.309%) HKD as at 2025/12/31 | | |
| | | 9.360 HKD | +0.015 | +0.161% | 3.02M | 28.27M | 9.198 (+1.761%) HKD as at 2025/12/31 | | |
| | FTSE China A50 Index | 15.380 HKD | +0.040 | +0.261% | 1.59M | 24.48M | 15.187 (+1.271%) HKD as at 2026/01/02 | | |
| | London Gold Fixing Price | 20.680 HKD | +0.080 | +0.388% | 890.70K | 18.41M | 20.609 (+0.345%) HKD as at 2026/01/02 | | |
| | Hang Seng High Dividend Yield Index | 30.500 HKD | -0.260 | -0.845% | 523.16K | 15.98M | 30.330 (+0.562%) HKD as at 2025/12/31 | | |
| | Hang Seng Index (net total return version) | 95.540 HKD | -0.100 | -0.105% | 156.42K | 14.98M | 93.201 (+2.510%) HKD as at 2025/12/31 | | |
| | FactSet Asia Semiconductor Index (net total return) | 101.600 HKD | +3.440 | +3.504% | 133.98K | 13.62M | 95.762 (+6.096%) HKD as at 2025/12/31 | | |
| | CSI 300 Index | 35.200 HKD | +0.240 | +0.686% | 384.00K | 13.44M | 34.657 (+1.567%) HKD as at 2025/12/31 | | |
| | FactSet China Semiconductor Index (net total return) | 61.180 HKD | +1.520 | +2.548% | 194.15K | 11.74M | 58.613 (+4.380%) HKD as at 2025/12/31 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index | 8.390 HKD | +0.120 | +1.451% | 1.38M | 11.50M | 8.080 (+3.840%) HKD as at 2025/12/31 | | |
| | Hang Seng Biotech Index | 3.606 HKD | +0.138 | +3.979% | 2.42M | 8.61M | 3.407 (+5.828%) HKD as at 2025/12/31 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average | 28.040 HKD | -0.980 | -3.377% | 292.29K | 8.18M | 29.738 (-5.710%) HKD as at 2026/01/02 | | |
| | FTSE US Treasury 20+ Years Index | 68.320 HKD | -0.080 | -0.117% | 109.92K | 7.52M | 68.442 (-0.178%) HKD as at 2025/12/31 | | |